Moxalactam therapy of Haemophilus influenzae type b meningitis in children.

[1]  G. McCracken,et al.  CEFTRIAXONE VERSUS AMPICILLIN AND CHLORAMPHENICOL FOR TREATMENT OF BACTERIAL MENINGITIS IN CHILDREN , 1983, The Lancet.

[2]  S. Kaplan,et al.  Moxalactam treatment of serious infections primarily due to Haemophilus influenzae type b in children. , 1983, Pediatrics.

[3]  M. Weitekamp,et al.  Prolonged bleeding times and bleeding diathesis associated with moxalactam administration. , 1983, JAMA.

[4]  M. H. Cheng.  Monitoring of serum pento barbital levels in pediatric intensive care patients utilizing high performance liquid chromatography method , 1982 .

[5]  D. Welch,et al.  Evaluation of Bactogen and Phadebact for detection of Haemophilus influenzae type b antigen in cerebrospinal fluid , 1982, Journal of clinical microbiology.

[6]  S. Shulman,et al.  Moxalactam in the treatment of pediatric infections. , 1982, American journal of diseases of children.

[7]  S. Moffitt,et al.  Clinical and pharmacokinetic evaluation of parenteral moxalactam in infants and children. , 1982, Antimicrobial Agents and Chemotherapy.

[8]  M. Marks,et al.  Activities of eight new beta-lactam antibiotics and seven antibiotic combinations against Neisseria meningitidis , 1982, Antimicrobial Agents and Chemotherapy.

[9]  G. Mccracken,et al.  Relation of concentrations of Haemophilus influenzae type b in cerebrospinal fluid to late sequelae of patients with meningitis. , 1982, The Journal of pediatrics.

[10]  R. Kauffman,et al.  Diffusion of moxalactam into the cerebrospinal fluid in children with bacterial meningitis. , 1981, The Journal of pediatrics.

[11]  E. Tuomanen,et al.  Oral chloramphenicol in the treatment of Haemophilus influenzae meningitis. , 1981, The Journal of pediatrics.

[12]  D. Anderson,et al.  Pharmacokinetics and cerebrospinal fluid penetration of moxalactam in children with bacterial meningitis. , 1981, The Journal of pediatrics.

[13]  G. Mccracken,et al.  Clinical evaluation of a new broad-spectrum oxa-beta-lactam antibiotic, moxalactam, in neonates and infants. , 1981, The Journal of pediatrics.

[14]  L. Thrupp,et al.  Meningitis due to Haemophilus influenzae type b resistant to ampicillin and chloramphenicol. , 1980, The Journal of pediatrics.

[15]  G. Mccracken,et al.  In vitro susceptibility of gram-negative bacilli from pediatric patients to moxalactam, cefotaxime, Ro 13-9904, and other cephalosporins , 1980, Antimicrobial Agents and Chemotherapy.

[16]  J. Kenny,et al.  Meningitis due to Haemophilus influenzae type b resistant to both ampicillin and chloramphenicol. , 1980, Pediatrics.

[17]  S. Menge,et al.  Identification of toxigenic Clostridium difficile by counterimmunoelectrophoresis , 1980, Journal of clinical microbiology.

[18]  D. Anderson,et al.  In vitro susceptibility of 104 clinical isolates of Haemophilus influenzae to moxalactam (LY127935), ampicillin, chloramphenicol, and ticarcillin , 1980, Antimicrobial Agents and Chemotherapy.

[19]  N. Rose,et al.  Manual of clinical immunology , 1976 .